Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sciegen Pharma is a generic pharmaceutical company based in Hauppauge, New York, dedicated to the development, manufacturing, and distribution of affordable prescription medicines. The company operates a state-of-the-art, FDA-approved manufacturing facility that specializes in oral solid dosage forms, including tablets and capsules. Sciegen's diverse product portfolio addresses various therapeutic areas such as cardiovascular health, central nervous system disorders, and metabolic conditions. By maintaining a robust supply chain and adhering to rigorous quality standards, the company ensures the delivery of safe and effective generic alternatives to the US market. Sciegen is an affiliate of the MSN Group, leveraging global R&D and manufacturing synergies to expand its reach. Their commitment to excellence is reflected in their modern infrastructure and continuous investment in complex generic formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sciegen Pharma.